Mechanism of Action of Semaglutide (Ozempic/Wegovy)
Introduction Semaglutide (Ozempic for diabetes; Wegovy for obesity) is a GLP‑1 receptor agonist used for type 2 diabetes mellitus … Read more
GLP‑1 Agonist
Mechanism of Action of Mounjaro (Tirzepatide)
Introduction Tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for obesity, is a dual GIP/GLP‑1 receptor … Read more